Neonatal DKA Management
For neonates presenting with diabetic ketoacidosis, initiate intravenous insulin at 0.05 units/kg/hour (NOT the standard pediatric dose of 0.05-0.10 units/kg/hour) along with appropriate fluid and electrolyte therapy, avoiding IV bolus insulin. 1
Initial Assessment and Diagnosis
Neonatal DKA is rare and often mimics sepsis, presenting with:
- Dehydration, fever, and weight loss
- Hyperglycemia with ketoacidosis
- May occur with pancreatic hypoplasia 2
Critical pitfall: Always consider DKA in any neonate presenting with apparent sepsis, dehydration, and unexplained metabolic acidosis. The presentation overlaps significantly with infection, making early recognition challenging 2, 3.
Insulin Therapy - Neonatal-Specific Dosing
The neonatal dose differs from older children:
- Neonatal IV insulin: 0.05 units/kg/hour 1
- Standard pediatric DKA: 0.05-0.10 units/kg/hour
- Never use IV bolus insulin in children or neonates with DKA 1
Goal: Gradually reduce blood glucose by 50-100 mg/dL per hour 1
Fluid Management
Based on the most recent evidence for pediatric DKA (applicable to neonates):
Initial resuscitation (first 20-30 minutes):
- Isotonic fluid bolus (normal saline or lactated Ringer's)
- Volume: 10-20 mL/kg 4
Ongoing fluid therapy:
- Continue isotonic fluids (0.9% NaCl)
- Repletion of volume deficit over 36 hours 4
- Consider D10W-containing IV fluids once glucose approaches 200-250 mg/dL 1
Critical update: Early isotonic fluid resuscitation does NOT increase cerebral edema risk and may improve outcomes. Older fluid-restricting protocols have not reduced cerebral injury incidence 4.
Electrolyte Monitoring and Replacement
Potassium:
- Monitor hourly or more frequently 1
- Begin replacement once adequate renal function is established
- Neonates are at high risk for both hypokalemia (from insulin therapy) and hyperkalemia (from acidosis)
Glucose:
- Monitor hourly initially 1
- Add dextrose to IV fluids when glucose <200-250 mg/dL to prevent hypoglycemia while continuing insulin to clear ketoacidosis
Transition to Subcutaneous Insulin
Once acidosis resolves:
- Transition to subcutaneous insulin (typically NPH or long-acting analog) 2
- Administer subcutaneous basal insulin 2-4 hours BEFORE stopping IV insulin to prevent rebound hyperglycemia and recurrent ketoacidosis 5
- Consider low-dose basal insulin analog alongside IV insulin during transition 5
Special Considerations for Neonates
Pancreatic insufficiency:
- If pancreatic hypoplasia is present, neonates may develop malabsorption
- Consider pancreatic enzyme replacement if frequent, watery stools develop with feeding 2
Feeding:
- Resume breastfeeding or formula at frequent intervals (every 3 hours) once stable 2
- Continue insulin therapy throughout
Monitoring for Complications
Cerebral injury/edema - the most feared complication:
- Monitor neurological status closely
- Signs: headache, altered mental status, bradycardia, increased blood pressure
- Risk factors: severe dehydration, younger age, new-onset diabetes
Avoid:
- Overly aggressive fluid resuscitation (though isotonic fluids are now preferred over restricted protocols)
- Rapid correction of hyperglycemia
- Bicarbonate therapy (generally not recommended and shows no benefit) 5, 6
Key Differences from Older Children
The neonatal-specific insulin dose (0.05 units/kg/hour) is at the lower end of the pediatric range, reflecting the unique physiology and increased sensitivity of neonates. This conservative approach minimizes hypoglycemia risk while effectively treating ketoacidosis.